BAYTRIL FLAVOUR TABLETS 15 MG

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Nusipirk tai dabar

Prekės savybės Prekės savybės (SPC)
13-05-2017

Veiklioji medžiaga:

ENROFLOXACIN

Prieinama:

Bayer Limited

ATC kodas:

QJ01MA90

INN (Tarptautinis Pavadinimas):

ENROFLOXACIN

Dozė:

15 mg/tablet

Vaisto forma:

Tablets

Recepto tipas:

POM

Farmakoterapinė grupė:

Canine, Feline

Gydymo sritis:

Enrofloxacin

Terapinės indikacijos:

Antibacterial

Autorizacija statusas:

Authorised

Leidimo data:

1988-10-01

Prekės savybės

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril Flavour Tablets 15 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For full list of excipients see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
A light brown to brown, slightly marbled, round, planar tablet for
oral administration to dogs and cats.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is for use in dogs and cats in the treatment of bacterial
infections of the alimentary, respiratory and urogenital
tracts, skin, secondary wound infections and otitis externa where
clinical experience, supported where possible by
sensitivity testing of the causal organism, indicates enrofloxacin as
the drug of the choice.
4.3 CONTRAINDICATIONS
Not for use in dogs less than 1 year of age or in exceptionally large
breeds of dog with a longer growth period under 18
months of age, as articular cartilage may be affected during the
period of rapid growth.
Not recommended for use in cats less than 8 weeks of age.
Baytril Flavour Tablets 15 mg should not be used for prophylaxis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Please refer to item 4.3.
Cats: Retinotoxic effects including blindness can occur when the
recommended dose is exceeded.
Active Constituents
mg/tablet
Enrofloxacin
15
Relevant constituents of the Excipient
Artificial beef flavour Irradiated.
6.0
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_
                                
                                Perskaitykite visą dokumentą
                                
                            

Ieškokite perspėjimų, susijusių su šiuo produktu

Peržiūrėti dokumentų istoriją